Research Article
miR-425-5p Acts as a Molecular Marker and Promoted Proliferation, Migration by Targeting RNF11 in Hepatocellular Carcinoma
Table 1
Correlations between miR-425-5p and clinicopathological features of HCC patients.
| Variables | Cases | miR-425-5p expression | | Low () | High () |
| Age (yr) | | | | | <50 | 48 | 15 | 33 | 0.874 | ≥50 | 57 | 17 | 40 | | Gender | | | | | Male | 60 | 19 | 41 | 0.760 | Female | 45 | 13 | 32 | | Tumor size (cm) | | | | | ≤5 | 50 | 14 | 36 | 0.599 | >5 | 55 | 18 | 37 | | AFP (ng/ml) | | | | | ≤20 | 38 | 12 | 26 | 0.853 | >20 | 67 | 20 | 47 | | TNM stage | | | | | I/II | 47 | 20 | 27 | 0.016 | III/IV | 58 | 12 | 46 | | Liver cirrhosis | | | | | Presence | 57 | 19 | 38 | 0.488 | Absence | 48 | 13 | 35 | | HBsAg | | | | | Positive | 65 | 21 | 44 | 0.603 | Negative | 40 | 11 | 29 | | Vascular invasion | | | | | Presence | 55 | 10 | 45 | 0.004 | Absence | 50 | 22 | 28 | | Multiplicity | | | | | Single | 42 | 18 | 24 | 0.024 | Multiple (≥2) | 63 | 14 | 49 | | Intrahepatic metastasis | | | | | Presence | 52 | 11 | 41 | 0.040 | Absence | 53 | 21 | 32 | |
|
|